The HER receptor family: a rich target for therapeutic development

This publication has 25 references indexed in Scilit:

• Untangling the ErbB signalling network
  Nature Reviews Molecular Cell Biology, 2001
• Kinase Inhibitors in Cancer Therapy
  Drugs, 2000
• Epidermal growth factor receptors: critical mediators of multiple receptor pathways
  Published by Elsevier ,1999
• EGF receptor
  The International Journal of Biochemistry & Cell Biology, 1999
• The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
  Proceedings of the National Academy of Sciences, 1999
• Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor
  Journal of Biological Chemistry, 1998
• Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials
  Annals of Oncology, 1997
• ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
  The EMBO Journal, 1997
• Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
  Proceedings of the National Academy of Sciences, 1994
• A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
  Proceedings of the National Academy of Sciences, 1985